The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
The Perfusion Paradox and Vascular Instability in Sickle Cell Disease
Abstract
Sickle cell disease (SCD) exhibits a curious coexistence of contrasting perfusion profiles in the circulatory system: hypoperfusion is endemic in microcirculatory beds occluded by hemoglobin S‐containing erythrocytes while hyperperfusion characterizes the systemic (macro)circulation and a number of regional vascular circuits. This review highlights this perfusion paradox of SCD, focusing on forearm blood flow and the renal circulation, and exploring the extent to which alterations in vasoactive systems (such as nitric oxide and prostanoids) are involved. Also reviewed are the mechanisms and pathways that contribute to altered vascular reactivity and vascular instability observed in SCD. Finally, the possibility that the induction of heme oxygenase‐1, recently described in SCD, may confer a protective response in the vasculature and other tissues is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both hypoperfusion of the microcirculation (due to microvascular occlusion or altered vasoregulation) and hyperperfusion of the systemic macrocirculation and major organ systems (due to anemia and fixed stenosis) coexist, a phenomenon that has been referred to as the perfusion paradox of SCD (132).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [132]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 2×
“Renal disease, as reflected by proteinuria, occurs in some 30% of patients while progressive decline in renal function leading to endstage renal disease occurs in up to 18% of patients (94,100), the latter substantially increasing morbidity and mortality observed in these patients (1,93,94).”
BackgroundCarbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 3×
“This inhibition of NO will impair important vascular functions of NO, such as vasodilation, platelet inhibition, and the tonic downregulation of VCAM-1 and E-selectin (96,97).”
BackgroundSelf-citationFerritin: a cytoprotective antioxidant strategem of endothelium.
Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J. W., & Vercellotti, G. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37165-0 · Cited by 1,097
Self-citationCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Biliverdin reductase: A major physiologic cytoprotectant
Barañano, D. E., Rao, M., Ferris, C. D., & Snyder, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252626999 · Cited by 1,088
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 974
Self-citationInduction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat.
Nath, K. A., Balla, G., Vercellotti, G. M., Balla, J., Jacob, H. S., Levitt, M. D., & Rosenberg, M. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115847 · Cited by 686
Self-citation
Research works printed but not linked: 4
- 10.1172/JCI200316672 · DOI · Paper page
- Embury S H, 1994, Sickle Cell Disease: Basic Principles and Clinical Practice, 311
- Kuvibidila S, 1997, Tumor necrosis factor α in children with sickle cell disease in stable condition, J Natl Med Assoc, 89, 609
- Nath K A, 1995, Contemporary Issues in Nephrology. “Acute renal failure: emerging concepts and therapeutic strategies”, 97
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationThe Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
HEBBEL, R. P., OSAROGIAGBON, R., & KAUL, D. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 463
“All in all, data seem consistent with sickle disease comprising a state of vascular instability due to concurrent upregulation of both vasodilatory and vasoconstricting processes (130).”
ResultSickle cell disease: renal manifestations and mechanisms
Nath, K. A., & Hebbel, R. P. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.8 · Cited by 369
Self-citationKato, G. J., Hebbel, R. P., Steinberg, M. H., & Gladwin, M. T. (2009) · American Journal of Hematology · doi:10.1002/ajh.21475 · Cited by 349
“Candidate contributory factors include polymerization-induced red cell sickling; a systemic inflammatory state [15] with abnormal expression of adhesion molecules for white blood cells and red blood cells [16–18]; activation of the coagulation system in terms of both platelets [19] and plasmatic coagulation, from its…”
BackgroundSelf-citationKato, G. J., Martyr, S., Blackwelder, W. C., Nichols, J. S., Coles, W. A., Hunter, L. A., Brennan, M., Hazen, S. L., & Gladwin, M. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05701.x · Cited by 207
“Thus, excessive endothelial activation and vaso-constriction because of impaired NO bioavailability may contribute to vascular instability in patients with SCD (Reiter et al, 2002; Reiter & Gladwin, 2003; Nath et al, 2004).”
BackgroundSelf-citation
Metadata
- Authors
- NATH, K. A., KATUSIC, Z. S., & GLADWIN, M. T.
- Affiliations
- Mayo Clinic (US)
- National Institutes of Health (US)
- Venue
- Microcirculation
- Publisher
- Wiley
- Published
- 2004-03
- Volume
- 11
- Issue
- 2
- Pages
- 179-193
- ISSN
- 1073-9688 (ISSN-L)
- 1549-8719
- OpenAlex
- W2069558664
- Cited by
- 102
- References
- 120
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 7 · 2019: 8 · 2018: 8 · 2017: 5 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 2 · 2012: 5
- FWCI
- 0.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Microcirculation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl055552-15)
- National Heart, Lung, and Blood Institute (P01 HL66958, P01HL066958, P01 HL55552)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK47060, R01DK047060)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- sickle cell disease, vascular instability, hypoperfusion, forearm blood flow, renal circulation, nitric oxide, prostanoids, vascular reactivity, heme oxygenase-1
- MeSH terms
- Anemia, Sickle Cell, Animals, Blood Flow Velocity, Endothelium, Vascular, Enzyme Activation, Forearm, Hemoglobin, Sickle, Humans, Nitric Oxide, Prostaglandins, Regional Blood Flow, Renal Circulation, Heme Oxygenase-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Perfusion Paradox and Vascular Instability in Sickle Cell Disease. https://app.cochat.ai/papers/10.1080/10739680490278592
- The paper
- NATH, K. A., KATUSIC, Z. S., & GLADWIN, M. T. (2004). The Perfusion Paradox and Vascular Instability in Sickle Cell Disease. Microcirculation. https://doi.org/10.1080/10739680490278592
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.